Srpt stock price target

Apr 06, 2016 · Sarepta Therapeutics (SRPT) stock is gaining on Wednesday as Oppenheimer raised its price target on the stock in anticipation of a positive outcome for its eteplirsen drug.

Apr 03, 2020 · Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. Sarepta Therapeutics Stock Forecast | SRPT Stock Predictions See SRPT stock predictions by 9 financial experts and find out if their Sarepta Therapeutics stock forecast (SRPT) is more bullish in comparison to other stocks in the Healthcare sector. Sarepta Therapeutics Stock Forecast: up to 153.559 USD ...

Sarepta Therapeutics (NASDAQ:SRPT) Price Target Cut to ...

Sarepta Therapeutics (NASDAQ:SRPT) Stock Price Down 8.7% ... Sarepta Therapeutics Inc (NASDAQ:SRPT) fell 8.7% on Monday following insider selling activity. The company traded as low as $105.89 and last traded at $106.87, 946,677 shares changed hands during mid-day trading. An increase of 9% from the average session volume of 865,163 shares. The stock had previously closed at $117.10. Specifically, EVP Alexander Cumbo sold […] Sarepta Therapeutics Earnings Release Date - SRPT ... That means we are expecting the stock SRPT to move 7%. If we sell Puts at strike price close to 14%, the stock is less likely to reach the strike price. As a result, Options for SRPT could expire worthless. You get to keep the whole premium. This is a short term Option strategy to take advantage of High Volatility from Earning Announcement of SRPT. JPMorgan Chase & Co. Cuts Sarepta Therapeutics (NASDAQ ... Sarepta Therapeutics (NASDAQ:SRPT) had its price target cut by JPMorgan Chase & Co. from $172.00 to $160.00 in a research note published on Friday, BenzingaRatingsTable reports. They currently have an overweight rating on the biotechnology company’s stock. Other analysts have also issued reports about the …

Nov 10, 2019 · 24 Wall Street analysts have issued ratings and price targets for Sarepta Therapeutics in the last 12 months. Their average twelve-month price target is $196.36, suggesting that the stock has a possible upside of 109.75%. The high price target for SRPT is …

Sarepta Therapeutics (NASDAQ:SRPT) Upgraded at BidaskClub ... Janney Montgomery Scott lifted their price target on shares of Sarepta Therapeutics from $160.00 to $175.00 and gave the stock a buy rating in a research note on Friday, December 13th. Piper Jaffray Companies reiterated a buy rating and set a $210.00 price target on shares of Sarepta Therapeutics in a research note on Monday, December 23rd. SRPT Stock Price, Financials & News | Stock Target Advisor Stock Target Advisor runs millions of automatic calculations on over 75,000 stocks in American, Asian and European Exchanges and compares it with market analyst stock ratings and target stock prices to help you make smart investment decisions and build robust investment portfolios.

Find the latest analyst research for Sarepta Therapeutics, Inc. Common Stock ( DE) (SRPT) at Nasdaq.com. Analyst price targets provided by TipRanks.

Sarepta Therapeutics (NASDAQ:SRPT) had its price target cut by JPMorgan Chase & Co. from $172.00 to $160.00 in a research note published on Friday, BenzingaRatingsTable reports. They currently have an overweight rating on the biotechnology company’s stock. Other analysts have also issued reports about the …

Is Sarepta Therapeutics Inc (SRPT) Stock a Good Value Tuesday? Tuesday, March 10, 2020 3:41 PM | InvestorsObserver Analysts. Is Sarepta Therapeutics Inc 

The average analyst SRPT price target for one year from now, presented by ETF difference to the ETF as far as deciding whether to continue to hold the stock. View today's stock price, news and analysis for Sarepta Therapeutics Inc. (SRPT) . Barron's also provides information on historical stock ratings, target prices,  GO IN-DEPTH ON Sarepta Therapeutics STOCK. Snapshot · LIVE QUOTE · Price · News · Financials · Analysts · Dividend · Calendar · Profile · Chart-Tool. 3 Mar 2020 Do Analysts Recommend You Should Buy Sarepta Therapeutics, Inc. (SRPT) Stock? Ad. On Monday, shares of Sarepta Therapeutics, Inc. View live SAREPTA THERAPEUTICS INC chart to track its stock's price action. Possible entry on break from symmetrical triangle $134.00 Target price  SRPT Sarepta Therapeutics, Inc. daily Stock Chart Feb-19-20 12:31PM, Analysts Estimate Sarepta Therapeutics (SRPT) to Report a Decline in Earnings: What  The stocks picks are: PTC Therapeutics (PTCT), Sarepta (SRPT), Ionis Sarepta price target raised to $217 from $211 at Cantor Fitzgerald » 06:56. 02/27/20.

Sarepta Therapeutics Stock Forecast: up to 153.559 USD ... Historical index on US Stock Market : B+ "Should I invest in Sarepta Therapeutics stock?" "Should I trade "SRPT" stock today?" According to our live Forecast System, Sarepta Therapeutics, Inc stock is an awesome long-term (1-year) investment*. "SRPT" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. Sarepta Therapeutics Inc : SRPT Stock Price Quote at Ally ... Analyst Actions: Cantor Lifts Price Target on Sarepta Therapeutics to $217 From $211, Reiterates Overweight 9:17AM ET 2/27/2020 MT Newswires. Sarepta Therapeutics (SRPT) has an average rating among analysts of buy, with an average price target of $198. TipRanks